The elevation of intracellular cyclic AMP by phosphodiesterase (PDE)4 inhibitors in eosinophils is associated with inhibition of the activation and recruitment of these cells. We have previously shown that systemic treatment with the PDE4 inhibitor rolipram effectively inhibt eosinophil migration in guinea pig skin. In the present study we compare the oral potency and efficacy of the PDE4 inhibitors rolipram, RP 73401 and CDP 840 on allergic and PAF-induced eosinophil recruitment. Rolipram and RP 73401 were equally effective and potent when given by the oral route and much more active than the PDE4 inhibitor CDP 840. We suggest that this guinea pig model of allergic and mediator-induced eosinophil recruitment is both a sensitive and simple ...
Phosphodiesterase (PDE) 4 inhibition is a well-known anti-inflam-matory mechanism, but the developme...
International audienceThe anti-inflammatory effects of CI-1044 and of the other selective PDE4 inhib...
We quantitatively determined whether the selective phosphodiesterase (PDE) inhibitor, rolipram, inhi...
Mem Inst Oswaldo Cruz, Rio de Janeiro, Vol. 92, Suppl. II, pp. 193-196 A comparison of the inhibitor...
YM976 is a novel and specific phosphodiesterase 4 inhibitor. In our previous report, we indicated th...
In the present study, we have performed a comparative analysis of the effect of selective inhibitors...
A new guinea pig model of allergic asthma was used to investigate the effects of low doses of the ph...
Selective inhibitors of the low-Km cAMP-specific phosphodies-terase (PDE4) inhibit inflammatory cell...
Mem Inst Oswaldo Cruz, Rio de Janeiro, Vol. 92, Suppl. II, pp. 201-204 Effect of selective phosphodi...
In a guinea pig model of allergic asthma, we investigated the effects of the selective phosphodieste...
The pharmacological profile of a novel cyclic nucleotide phosphodiesterase (PDE) inhibitor, Org 2024...
Phosphodiesterase (PDE) 4 inhibition is a well-known anti-inflam-matory mechanism, but the developme...
International audienceThe anti-inflammatory effects of CI-1044 and of the other selective PDE4 inhib...
We quantitatively determined whether the selective phosphodiesterase (PDE) inhibitor, rolipram, inhi...
Mem Inst Oswaldo Cruz, Rio de Janeiro, Vol. 92, Suppl. II, pp. 193-196 A comparison of the inhibitor...
YM976 is a novel and specific phosphodiesterase 4 inhibitor. In our previous report, we indicated th...
In the present study, we have performed a comparative analysis of the effect of selective inhibitors...
A new guinea pig model of allergic asthma was used to investigate the effects of low doses of the ph...
Selective inhibitors of the low-Km cAMP-specific phosphodies-terase (PDE4) inhibit inflammatory cell...
Mem Inst Oswaldo Cruz, Rio de Janeiro, Vol. 92, Suppl. II, pp. 201-204 Effect of selective phosphodi...
In a guinea pig model of allergic asthma, we investigated the effects of the selective phosphodieste...
The pharmacological profile of a novel cyclic nucleotide phosphodiesterase (PDE) inhibitor, Org 2024...
Phosphodiesterase (PDE) 4 inhibition is a well-known anti-inflam-matory mechanism, but the developme...
International audienceThe anti-inflammatory effects of CI-1044 and of the other selective PDE4 inhib...
We quantitatively determined whether the selective phosphodiesterase (PDE) inhibitor, rolipram, inhi...